Q: With Zoetis off about 33% from the late 2021 highs, what is your opinion on its prospects? Growth metrics seem to be attractive and valuation looks more reasonable...Thanks
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I am down by 55% on this company, although it is a small position (.8%) & I consider it speculative. Your comments will help me decide to wait, sell, or buy more. Thanks
Q: acquisition of the Biodex - -Do you feel this is a positive step. I feel in the past, you had high regards of management. Do you feel this stock is under priced. Would you give it a buying rate.
Also, on the 2 previous questions, how would you rate them.
Also, on the 2 previous questions, how would you rate them.
-
Amazon.com Inc. (AMZN)
-
The Cigna Group (CI)
-
Humana Inc. (HUM)
-
JPMorgan Chase & Co. (JPM)
-
UnitedHealth Group Incorporated (DE) (UNH)
-
Berkshire Hathaway Inc. (BRK.B)
-
Elevance Health Inc. (ELV)
Q: I have been watching UNH since the Bush years when it was going through rapid mergers and Buffett was buying it up. It wasn’t going up during the Obama presidency at least early on as investors were looking at the impact of public insurance.
Could you please comment on its significant success since and the business model of American health insurers now and in the future?
Could you please comment on its significant success since and the business model of American health insurers now and in the future?
Q: For a little guy this company looks very strong to me. I am already up a lot and am expecting a lot more. I would be interested in your opinion. Thx James
Q: When I listen to Knight's analyst conference calls after reviewing their latest results, I am very unimpressed with management's attitude towards "just doing better". The same four executives have been at the helm for at least six years and the stock price is down by half. They are the only ones making money. I wish Goodman would clean house or maybe it's time for him to go, as well. This company is a major disappointment and needs some fresh initiatives from a brand new group. Their performance is embarrassing.
Do you think this Company, that seems to have so much potential, will ever accomplish anything beyond mediocre performance? It's time for new blood. The present team is too rich and definitely not hungry for success. What do you think?
Do you think this Company, that seems to have so much potential, will ever accomplish anything beyond mediocre performance? It's time for new blood. The present team is too rich and definitely not hungry for success. What do you think?
Q: Any additional thoughts on WELL following the conference call yesterday? The company seems well positioned for the changes going on in Canadian health care. Thank-you.
Q: I know in your last answer you indicated you had simply run out of patience with GUD. Wondering what your thoughts are now ? Outside of some major move (maybe a buyout or privatization) do you see much chance for significant capital appreciation over the next year. I'm down over $5K on 2000 shares ...wondering if I should just move on ...and if so, any suggestions (maybe HHL) ?
Q: Hello 5i team,
Your thoughts on Knight's latest earnings? Is there any life left in this stock?
Thanks,
Andrew
Your thoughts on Knight's latest earnings? Is there any life left in this stock?
Thanks,
Andrew
Q: Curious to see Knight back to all time lows despite so much promise in years past with all their cash and careful approach; we sold it long ago but wonder what did or didn't happen here ?
Q: WELL reported this morning. Looked strong across the board. Can you comment and provide your thoughts before call later today.
Q: Hi Peter
What are the expectations for WELL financials (REV and Adj EBITDA) for Q4 and Full Year. Also at these price levels is it a buy, sell or hold.
Thank you
What are the expectations for WELL financials (REV and Adj EBITDA) for Q4 and Full Year. Also at these price levels is it a buy, sell or hold.
Thank you
Q: hello 5i:
recently, I asked a question about LIFE; thanks for the quick response. In hindsight, what I should have asked might have been: which covered call ETF, in the health care space, provides the best dividend rate, with the lowest return of capital. As we're dealing in registered accounts, return of capital is not of interest to me.
thanks
Paul L
recently, I asked a question about LIFE; thanks for the quick response. In hindsight, what I should have asked might have been: which covered call ETF, in the health care space, provides the best dividend rate, with the lowest return of capital. As we're dealing in registered accounts, return of capital is not of interest to me.
thanks
Paul L
Q: Your thoughts please on the latest quarter?
Thx
Thx
Q: WELL down 5%+ of heavy volume late Wednesday. Don't see any news. Any explanation for the move?
-
Amgen Inc. (AMGN)
-
CVS Health Corporation (CVS)
-
Eli Lilly and Company (LLY)
-
UnitedHealth Group Incorporated (DE) (UNH)
-
Ninepoint Energy Income FUnd (NRGI)
Q: Hi group i presently hold CVS - 20% loss,- UNH - 11% loss Buy sell or old ? + if sell what would you replace with (these are my only holds in health sector this sector is really struggling - your comments on the sector + these 2 stocks in general
I also own NRGI - presently a 20% loss I also own ARC in this sector presently 5% loss - your thoughts on the sector in general + But sell or Hold
thanks for your help with my portfolio
I also own NRGI - presently a 20% loss I also own ARC in this sector presently 5% loss - your thoughts on the sector in general + But sell or Hold
thanks for your help with my portfolio
Q: Hello 5i,
I have reviewed the questions on these two ETF's and I would like to confirm my thinking. I need to increase both my international and U.S. sectors, one more than the other. As I understand it, if I purchase LIFE, then my international sector would improve over HHL and if I purchase HHL, then my U.S. sector would improve over LIFE. Beyond geographic sector allocation I am largely indifferent albeit with a slight preference for HHL more due to its MER more than anything else.
So, are my assumptions correct and would you have anything further to add in terms of preferring one over the other that I may have overlooked?
Many thanks as always!!!
Cheers,
Mike
I have reviewed the questions on these two ETF's and I would like to confirm my thinking. I need to increase both my international and U.S. sectors, one more than the other. As I understand it, if I purchase LIFE, then my international sector would improve over HHL and if I purchase HHL, then my U.S. sector would improve over LIFE. Beyond geographic sector allocation I am largely indifferent albeit with a slight preference for HHL more due to its MER more than anything else.
So, are my assumptions correct and would you have anything further to add in terms of preferring one over the other that I may have overlooked?
Many thanks as always!!!
Cheers,
Mike
Q: I bought this stock a few years back, it pays a consistent dividend but little value add outside of that. I am thinking of selling and moving into other US pharma with better growth upside. What are your thoughts and a couple of recommendations for alternatives.
As always thanks for your advise.
Jim
As always thanks for your advise.
Jim
Q: When does WELL intend to release 4th quarter and year end 2022 financial results?
Q: CSTL Could you comment on earnings, revs are up 53 %, they guided to almost double them by 2025. Business here looks good. Cash flow did decrease based on acquisitions... is this a company building a profitable, invest-able future? Your thoughts?